What is EvolutionaryScale?
EvolutionaryScale is dedicated to developing artificial intelligence to comprehend biology, aiming to enhance human health and societal well-being through open, safe, and responsible research. The company's vision is to leverage AI to make molecules and entire cells programmable, positioning itself to create frontier models for biology that will drive transformative advancements in biological design over the next decade.
How much funding has EvolutionaryScale raised?
EvolutionaryScale has raised a total of $142M across 1 funding round:
Angel/Seed
$142M
Angel/Seed (2024): $142M with participation from Lux Capital
Key Investors in EvolutionaryScale
Lux Capital
Lux Capital is a New York-based venture capital firm specializing in early-stage and growth-stage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials.
What's next for EvolutionaryScale?
The substantial enterprise-level funding and recent strategic investment signal a phase of accelerated growth and development for EvolutionaryScale. This capital infusion is expected to fuel the company's mission to build advanced AI models for biology, enabling a new era of programmable biological design. The focus on responsible research and scientific partnership suggests a strategic approach to scaling its impact in the health and biotechnology sectors.
See full EvolutionaryScale company page
